Reduced cardiac functional reserve and quality of life in adults with GH deficiency

被引:2
|
作者
Moisey, Robert [1 ]
Barker, Diane [2 ,3 ]
Lewis, Nigel [2 ,3 ]
Sharp, Lisa [4 ]
Clements, Richard E. [4 ]
Goldspink, David F. [4 ]
Tan, Lip-Bun [2 ,3 ]
Orme, Steve [1 ]
机构
[1] Leeds Gen Infirm, Dept Endocrinol, Leeds LS1 3EX, W Yorkshire, England
[2] Univ Leeds, Acad Unit Mol Cardiovasc Res, Leeds, W Yorkshire, England
[3] Leeds Gen Infirm, Yorkshire Heart Ctr, Leeds LS1 3EX, W Yorkshire, England
[4] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Human Dev & Ageing Res Unit, Liverpool L3 5UX, Merseyside, England
关键词
GROWTH-HORMONE DEFICIENCY; LEFT-VENTRICULAR FUNCTION; PREMATURE MORTALITY; CARDIOVASCULAR RISK; REPLACEMENT THERAPY; BODY-COMPOSITION; ELDERLY-PATIENTS; HEART-FAILURE; HYPOPITUITARISM; PERFORMANCE;
D O I
10.1111/j.1365-2265.2009.03560.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Introduction Patients with severe GH deficiency (GHD) suffer with a reduced quality of life in addition to diverse changes in cardiac size and performance. So far, the cardiac reserve ability to maintain the circulation during peak exercise has not been measured. We tested the hypothesis that patients with severe GHD have reduced cardiac reserve function compared with healthy controls and that this could explain, in part, their reduced quality of life. Aims Eighteen patients with severe GHD and an assessment of GHD in adults (AGHDA) score >= 11 (mean 20 center dot 0, range 12-25) were studied and compared with 18 age-, sex- and body mass index-matched healthy controls. Peak cardiac power and cardiorespiratory fitness were investigated using noninvasive haemodynamic measurements during maximal cardiopulmonary exercise testing. Results Compared with matched controls, the cardiac power of GHD patients during exercise to volitional exhaustion was significantly reduced by 15% (mean +/- SD 4 center dot 4 +/- 1 center dot 0 W vs. 5 center dot 2 +/- 1 center dot 0 W, P = 0 center dot 02). Patients with GHD also had lower cardiac chronotropic reserve (peak heart rate 154 +/- 21/min vs. 174 +/- 11/min, P = 0 center dot 001) and a lower cardiac pressure-generating capacity (systolic blood pressure 160 +/- 25 mmHg vs. 200 +/- 15 mmHg, P < 0 center dot 0001). We found no correlation between any measure of peak cardiac power or function and the AGHDA score. Conclusion Using this robust noninvasive method of assessing functional cardiac pumping capacity, we have for the first time shown that, while patients with severe GHD have a significantly impaired cardiac functional reserve associated with chronotropic incompetence and impaired pressure-generating capacity, this does not correlate with their reduced quality of life assessed using the current standard AGHDA score.
引用
收藏
页码:543 / 548
页数:6
相关论文
共 50 条
  • [21] Measuring quality of life in adults with growth hormone deficiency
    Wallymahmed, M
    Baker, G
    Humphris, G
    MacFarlane, I
    CLINICAL ENDOCRINOLOGY, 1996, 45 (04) : 507 - 508
  • [22] Growth hormone deficiency and quality of life in hypopituitary adults
    Johnston, DG
    CLINICAL ENDOCRINOLOGY, 1997, 46 (04) : 407 - 408
  • [23] Quality of life in children and adults with growth hormone deficiency
    Wiklund, IK
    Erling, AE
    Albertsson-Wikland, K
    THERAPEUTIC OUTCOME OF ENDOCRINE DISORDERS: EFFICACY, INNOVATION AND QUALITY OF LIFE, 2000, : 21 - 29
  • [24] Quality of life at adult height in adolescents and young adults treated by GH
    Briceno, Laura Gonzalez
    Magali, Viaud
    Beltrand, Jacques
    Flechtner, Isabelle
    Dassa, Yamina
    Samara-Boustani, Dinane
    Thalassinos, Caroline
    Busiah, Kanetee
    Pinto, Graziella
    Jaquet, Delphine
    Polak, Michel
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 288 - 288
  • [25] Influences on quality of life in GH deficient adults and their effect on response to treatment
    Murray, RD
    Skillicorn, CJ
    Howell, SJ
    Lissett, CA
    Rahim, A
    Smethurst, LE
    Shalet, SM
    CLINICAL ENDOCRINOLOGY, 1999, 51 (05) : 565 - 573
  • [26] Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index:: a precursor to cost-utility analysis
    Koltowska-Haggstrom, Maria
    Kind, Paul
    Monson, John P.
    Jonsson, Bjorn
    CLINICAL ENDOCRINOLOGY, 2008, 68 (01) : 122 - 129
  • [27] The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults
    Gilchrist, FJ
    Murray, RD
    Shalet, SM
    CLINICAL ENDOCRINOLOGY, 2002, 57 (03) : 363 - 370
  • [28] Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency
    Peixoto Cenci, Maria Claudia
    Soares, Debora Vieira
    Carneiro Spina, Luciana Diniz
    de Lima Oliveira Brasil, Rosane Resende
    Lobo, Priscila Marise
    Mansur, Vera Aleta
    Gold, Jaime
    Michmacher, Eduardo
    Vaisman, Mario
    Conceicao, Flavia Lucia
    PITUITARY, 2009, 12 (04) : 322 - 329
  • [29] Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiency
    Maria Claudia Peixoto Cenci
    Débora Vieira Soares
    Luciana Diniz Carneiro Spina
    Rosane Resende de Lima Oliveira Brasil
    Priscila Marise Lobo
    Vera Aleta Mansur
    Jaime Gold
    Eduardo Michmacher
    Mario Vaisman
    Flávia Lúcia Conceição
    Pituitary, 2009, 12 : 322 - 329
  • [30] Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency
    Prodam, F.
    Caputo, M.
    Belcastro, S.
    Garbaccio, V.
    Zavattaro, M.
    Sama, M. T.
    Bellone, S.
    Pagano, L.
    Bona, G.
    Aimaretti, G.
    PANMINERVA MEDICA, 2012, 54 (04) : 323 - 331